Literature DB >> 20447617

Intranasal arginine vasopressin enhances the encoding of happy and angry faces in humans.

Adam J Guastella1, Amanda R Kenyon, Gail A Alvares, Dean S Carson, Ian B Hickie.   

Abstract

BACKGROUND: Arginine vasopressin (AVP) has a complex but crucial role in social behavior. In nonhuman mammals it facilitates social recognition and bonding while also promoting defensive, aggressive, and territorial behaviors. There has been little research in humans exploring its effect on social cognition, including the encoding of social memories.
METHODS: In a double-blind, randomized, placebo-controlled, between-subject design, we administered AVP (20 IU) or a placebo intranasally to 48 healthy human male volunteers and then presented 54 happy, angry, or neutral human faces. Participants returned the following day to make "remember", "know", or "new" judgments for a mix of 108 new and previously seen faces.
RESULTS: Participants who were administered AVP were more likely to make know judgments for previously seen happy and angry faces in comparison with neutral human faces. Arginine vasopressin did not influence judgments for faces that had not been presented previously.
CONCLUSIONS: Administration of AVP to male humans enhances the encoding of both happy and angry social information to make this more memorable. Results suggest that AVP could facilitate both bonding and aggressive related behaviors in humans by enhancing the encoding of positive and negative social cues within everyday interactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447617     DOI: 10.1016/j.biopsych.2010.03.014

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  38 in total

1.  Interaction of stress, corticotropin-releasing factor, arginine vasopressin and behaviour.

Authors:  Eléonore Beurel; Charles B Nemeroff
Journal:  Curr Top Behav Neurosci       Date:  2014

2.  Neuroticism modulates the effects of intranasal vasopressin treatment on the neural response to positive and negative social interactions.

Authors:  Chunliang Feng; Ashley C DeMarco; Ebrahim Haroon; James K Rilling
Journal:  Neuropsychologia       Date:  2015-05-12       Impact factor: 3.139

Review 3.  New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition.

Authors:  Elizabeth C Finger
Journal:  J Mol Neurosci       Date:  2011-05-27       Impact factor: 3.444

Review 4.  Neuropeptide Regulation of Social Attachment: The Prairie Vole Model.

Authors:  Manal Tabbaa; Brennan Paedae; Yan Liu; Zuoxin Wang
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

5.  Sex-specific modulation of juvenile social play by vasopressin.

Authors:  Alexa H Veenema; Remco Bredewold; Geert J De Vries
Journal:  Psychoneuroendocrinology       Date:  2013-07-07       Impact factor: 4.905

Review 6.  The animal and human neuroendocrinology of social cognition, motivation and behavior.

Authors:  Cade McCall; Tania Singer
Journal:  Nat Neurosci       Date:  2012-04-15       Impact factor: 24.884

Review 7.  Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.

Authors:  Andreas Meyer-Lindenberg; Gregor Domes; Peter Kirsch; Markus Heinrichs
Journal:  Nat Rev Neurosci       Date:  2011-08-19       Impact factor: 34.870

8.  Diminished gray matter within the hypothalamus in autism disorder: a potential link to hormonal effects?

Authors:  Florian Kurth; Katherine L Narr; Roger P Woods; Joseph O'Neill; Jeffry R Alger; Rochelle Caplan; James T McCracken; Arthur W Toga; Jennifer G Levitt
Journal:  Biol Psychiatry       Date:  2011-05-04       Impact factor: 13.382

9.  Sex differences in vasopressin 1a receptor regulation of social communication within the lateral habenula and dorsal raphe of mice.

Authors:  Nicole Rigney; Rachael Beaumont; Aras Petrulis
Journal:  Horm Behav       Date:  2020-03-10       Impact factor: 3.587

10.  Posttraumatic stress disorder and partner-specific social cognition: a pilot study of sex differences in the impact of arginine vasopressin.

Authors:  Amy D Marshall
Journal:  Biol Psychol       Date:  2013-03-05       Impact factor: 3.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.